Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 96

1.

Recurrent Glioblastoma Treated With Recombinant Poliovirus.

Schneider JR, Patel NV, Kwan K, Boockvar JA.

Neurosurgery. 2018 Nov 1;83(5):E200. doi: 10.1093/neuros/nyy400. No abstract available.

PMID:
30321417
2.

Recurrent Glioblastoma Treated with Recombinant Poliovirus.

Desjardins A, Gromeier M, Herndon JE 2nd, Beaubier N, Bolognesi DP, Friedman AH, Friedman HS, McSherry F, Muscat AM, Nair S, Peters KB, Randazzo D, Sampson JH, Vlahovic G, Harrison WT, McLendon RE, Ashley D, Bigner DD.

N Engl J Med. 2018 Jul 12;379(2):150-161. doi: 10.1056/NEJMoa1716435. Epub 2018 Jun 26.

3.

Targeted therapy for glioblastoma multiforme neoplastic meningitis with intrathecal delivery of an oncolytic recombinant poliovirus.

Ochiai H, Campbell SA, Archer GE, Chewning TA, Dragunsky E, Ivanov A, Gromeier M, Sampson JH.

Clin Cancer Res. 2006 Feb 15;12(4):1349-54.

4.

Cytotoxic and immunogenic mechanisms of recombinant oncolytic poliovirus.

Brown MC, Gromeier M.

Curr Opin Virol. 2015 Aug;13:81-5. doi: 10.1016/j.coviro.2015.05.007. Epub 2015 Jun 12. Review.

5.

Comment to "Recurrent Glioblastoma Treated with Recombinant Poliovirus".

Wang P, Chen GZ.

Chin Med J (Engl). 2018 Nov 5;131(21):2645-2646. doi: 10.4103/0366-6999.244121. No abstract available.

6.

Recombinant oncolytic poliovirus eliminates glioma in vivo without genetic adaptation to a pathogenic phenotype.

Dobrikova EY, Broadt T, Poiley-Nelson J, Yang X, Soman G, Giardina S, Harris R, Gromeier M.

Mol Ther. 2008 Nov;16(11):1865-72. doi: 10.1038/mt.2008.184. Epub 2008 Sep 2.

7.

Preparing an oncolytic poliovirus recombinant for clinical application against glioblastoma multiforme.

Goetz C, Gromeier M.

Cytokine Growth Factor Rev. 2010 Apr-Jun;21(2-3):197-203. doi: 10.1016/j.cytogfr.2010.02.005. Epub 2010 Mar 17. Review.

8.

Engineered Oncolytic Poliovirus PVSRIPO Subverts MDA5-Dependent Innate Immune Responses in Cancer Cells.

Walton RW, Brown MC, Sacco MT, Gromeier M.

J Virol. 2018 Sep 12;92(19). pii: e00879-18. doi: 10.1128/JVI.00879-18. Print 2018 Oct 1.

PMID:
29997212
9.

Oncolytic poliovirus against malignant glioma.

Goetz C, Dobrikova E, Shveygert M, Dobrikov M, Gromeier M.

Future Virol. 2011 Sep;6(9):1045-1058.

10.

Evaluation of IRES-mediated, cell-type-specific cytotoxicity of poliovirus using a colorimetric cell proliferation assay.

Yang X, Chen E, Jiang H, Muszynski K, Harris RD, Giardina SL, Gromeier M, Mitra G, Soman G.

J Virol Methods. 2009 Jan;155(1):44-54. doi: 10.1016/j.jviromet.2008.09.020. Epub 2008 Nov 8.

11.

Pretreatment ADC histogram analysis is a predictive imaging biomarker for bevacizumab treatment but not chemotherapy in recurrent glioblastoma.

Ellingson BM, Sahebjam S, Kim HJ, Pope WB, Harris RJ, Woodworth DC, Lai A, Nghiemphu PL, Mason WP, Cloughesy TF.

AJNR Am J Neuroradiol. 2014 Apr;35(4):673-9. doi: 10.3174/ajnr.A3748. Epub 2013 Oct 17.

12.

Recombinant Poliovirus for Cancer Immunotherapy.

Gromeier M, Nair SK.

Annu Rev Med. 2018 Jan 29;69:289-299. doi: 10.1146/annurev-med-050715-104655.

13.
14.

Genomic features of intertypic recombinant sabin poliovirus strains excreted by primary vaccinees.

Cuervo NS, Guillot S, Romanenkova N, Combiescu M, Aubert-Combiescu A, Seghier M, Caro V, Crainic R, Delpeyroux F.

J Virol. 2001 Jul;75(13):5740-51.

15.
16.

Glioblastoma multiforme: the terminator.

Holland EC.

Proc Natl Acad Sci U S A. 2000 Jun 6;97(12):6242-4. No abstract available.

19.

Limited impact of prognostic factors in patients with recurrent glioblastoma multiforme treated with a bevacizumab-based regimen.

Tabouret E, Barrie M, Thiebaut A, Matta M, Boucard C, Autran D, Loundou A, Chinot O.

J Neurooncol. 2013 Sep;114(2):191-8. doi: 10.1007/s11060-013-1170-y. Epub 2013 Jun 12.

PMID:
23756726
20.

A seroprevalence study of poliovirus antibody against a collection of recombinant and non-recombinant poliovirus vaccine strains in the population of southern Greece.

Pliaka V, Ruether IG, Kyriakopoulou Z, Kioussi P, Plakokefalos E, Megalou M, Pratti A, Levidiotou-Stefanou S, Markoulatos P.

Clin Microbiol Infect. 2010 Nov;16(11):1672-5. doi: 10.1111/j.1469-0691.2010.03188.x.

Supplemental Content

Support Center